Feature|Videos|September 6, 2000
Projecting Pharma's Outlook with Deloitte's Laks Pernenkil
Author(s)Grant Playter
Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry.
Advertisement
Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry with Grant Playter, associate editor. Topics of discussion include Deloitte’s recent report on the state of biopharma, broader digitalization trends, how generative AI will affect pharma going forward, the push toward supply chain resilience, and more.
About the speaker
[insert text]
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Documentation Reliability Across Contractors: A Quality Systems Approach
3
What to Know About Regulations in June 2026
4
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
5